A prospective randomized controlled trial of AJG522 versus standard PEG plus E as bowel preparation for colonoscopy

A prospective randomized controlled trial of AJG522 versus standard PEG plus E as bowel preparation for colonoscopy - AJG522 versus PEG plus E for colonoscopy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013892

Enrollment

Registered

2014-05-06

Start date

2013-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis and so on

Interventions

AJG522 PEG plus E (Niflec&amp

#174

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Inpatients who are scheduled to receive colonoscopy. 2)consenting study subjects. 2)written informed consent was achieved.

Exclusion criteria

Exclusion criteria: Subjects had any of the following: a history of colonic resection; ileus; gastrointestinal obstruction or perforation; severe inflammatory bowel disease, such as toxic megacolon; heart failure (New York Heart Association [NYHA] Class III or IV); acute life-threatening cardiovascular disease; untreated or uncontrolled hypertension; severe liver failure; severe psychosomatic disease; or end-stage renal insufficiency. Hospitalized patients

Design outcomes

Primary

Measure	Time frame
The fecal properties as a bowel cleansing condition for the colonoscopy via the macroscopic observation of stool.	—

Secondary

Measure	Time frame
Taste, acceptability, willingness to repeat, patient satisfaction, and adverse events	—

Countries

Japan

Contacts

Public ContactToshihiko Sagawa

Gunma University Graduate School of Medicine Department of Medicine and Molecular Science

m07702015@gunma-u.ac.jp027-220-8137

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026